PBG BioPharma Inc., (PBG), a phytochemical biopharmaceutical group, has announced its receipt of a manufacturing site license issued by the Natural and Non-prescription Health Products Directorate (NNHPD) of Health Canada for the manufacturing, packaging, and labeling of natural health products at its facility in Leduc, Alberta.
The license allows PBG to diversify its GMP-compliant manufacturing business by adding natural health products such as nutraceuticals, herbal remedies, vitamins, minerals, and other non-prescription over-the-counter therapeutics to its current Health Canada license Hemp and Cannabis related processing/manufacturing and analytical businesses.
The company’s 25,000 square foot state-of-the-art biopharmaceutical facility houses multiple purpose-built manufacturing units and analytical/research laboratories, including a suite of GMP compliant and ISO 17025 accredited laboratories for analytical testing, research, and formulation development of natural health products, a Health Canada licensed GMP cannabis/hemp processing and manufacturing facility.
Each functional unit occupies a dedicated space in the facility that is separate from other available units. Together, these facilities serve as a one-stop shop for companies seeking to develop, test, and manufacture high-quality science-based natural health and hemp/cannabis products.
This site license confirms PBG’s good manufacturing practices that ensure an effective overall product quality control and risk management approach. By utilizing its cornerstone GenBioChem® Triple Fingerprinting Technology, PBG endeavors to meet its scientific and manufacturing practice’s peak scientific and quality standards.
“Receiving this critical natural health product manufacturing site license signifies another major milestone our company has achieved. We are now in a better position to develop and commercialize science-based nutraceuticals and herbal medicines and serve other NHP industries looking to manufacture and launch their own innovative natural health products,” said Dr. Jacqueline Shan, Founder, President, and CEO of PBG BioPharma Inc.